Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenfuqingpi Tang granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by ShuGuang Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine, for the treatment of septic shock. The formula is a specific modification of the classic Shenfu Tang, typically composed of *Panax ginseng* (Ren Shen) and *Aconitum carmichaelii* (Fu Zi), with the addition of *Citrus reticulata* (Qing Pi; Green Tangerine Peel). It is designed to address "yang exhaustion" and circulatory collapse by improving microcirculation, stabilizing hemodynamics, and reducing organ failure scores. In clinical trial settings, it is administered as an adjunctive therapy alongside standard guideline-based sepsis care to facilitate shock reversal and improve patient survival in intensive care units.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shenfuqingpi tang granules.